Characteristic | Odds ratio | 95%CI | P-value |
---|---|---|---|
Univariate analysis | |||
Gender, male | 0.824 | 0.509–1.334 | 0.431 |
Age at diagnosis, years | 1.021 | 1.006–1.036 | 0.005* |
Tumor size, cm | 0.981 | 0.932–1.032 | 0.449 |
Tumor number | 1.084 | 0.886–1.328 | 0.432 |
Capsule | 1.094 | 0.695–1.721 | 0.699 |
Tumor grade | 0.940 | 0.698–1.266 | 0.685 |
Macrovascular invasion | 0.842 | 0.440–1.610 | 0.603 |
Microvascular invasion | 0.760 | 0.493–1.170 | 0.212 |
Cirrhosis | 1.072 | 0.713–1.613 | 0.737 |
Ascites | 3.223 | 1.264–8.215 | 0.014* |
Alcoholism | 0.845 | 0.533–1.340 | 0.475 |
HBV | 0.710 | 0.458–1.101 | 0.126 |
HCV | 1.839 | 1.148–2.945 | 0.011* |
HBV + HCV | 1.291 | 0.644–2.588 | 0.471 |
NBNC | 0.848 | 0.479–1.502 | 0.572 |
Prothrombin time, second | 0.938 | 0.811–1.084 | 0.385 |
AST, U/L | 1.002 | 0.999–1.005 | 0.246 |
ALT, U/L | 1.003 | 1.000–1.005 | 0.095 |
Bilirubin, mg/dL | 0.960 | 0.808–1.142 | 0.646 |
Albumin, g/dL | 0.820 | 0.572–1.175 | 0.279 |
Creatinine, mg/dL | 0.976 | 0.790–1.206 | 0.823 |
Alpha-fetoprotein, ng/mL | 1.000 | 1.000–1.000 | 0.377 |
Recurrent | 1.208 | 0.806–1.811 | 0.359 |
Recurrent time, month | 0.995 | 0.988–1.001 | 0.113 |
Metastasis | 0.692 | 0.415–1.156 | 0.160 |
Metastatic time, month | 0.998 | 0.991–1.004 | 0.435 |
Death | 0.767 | 0.416–1.414 | 0.395 |
Survival time, month | 0.998 | 0.992–1.005 | 0.632 |
Multivariate analysis | |||
Age, years | 1.016 | 1.001–1.032 | 0.037* |
Ascites | 3.505 | 1.358–9.048 | 0.010* |
HCV | 1.646 | 0.999–2.713 | 0.050 |